Atrial Natriuretic Peptide (3-28), human

Atrial Natriuretic Peptide (3-28), human retains the central cyclic domain crucial for structural integrity and ligand recognition. Its amphipathic and charged residues support folding and docking investigations. The fragment aids in mapping structure-function relationships in natriuretic systems. Applications include biophysical modeling and motif engineering.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: A17026

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C117H187N43O36S3
M.W/Mr.
2880.3
Sequence
RRSSCFGGRMDRIGAQSGLGCNSFRY
Length
26

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide Synthesis ServicesCustom Conjugation ServicePeptide Analysis ServicesEpitope Mapping ServicescGMP Peptide ServicePeptide Modification ServicesPeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers